Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

Novo Nordisk CEO Lars Fruergaard Jørgensen defended the company's lawsuit against Eli Lilly concerning advertising practices for weight-loss drugs. The lawsuit allegations and specific claims were not detailed in the available information. Jørgensen stated that "competition has to be fair," according to the headline attribution.

Next story